Parameters of high-density lipoproteins in patients with arterial hypertension in combination with other components of metabolic syndrome

被引:0
|
作者
I. N. Ozerova
N. V. Perova
N. V. Shchel’tsyna
M. N. Mamedov
机构
[1] Federal Agency on Health Care and Social Development,Department of Metabolic Disorders, State Research Center for Preventive Medicine
关键词
high-density lipoproteins; phospholipids; apoprotein A1; arterial hypertension; metabolic syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
Parameters of HDL (concentrations of cholesterol, apoprotein A1, and phospholipids and phospholipid composition) determining their functional properties were studied in patients with arterial hypertension in combination with other components of metabolic syndrome (abdominal obesity, hyperlipidemia, and impaired glucose tolerance). Patients with isolated arterial hypertension did not differ from the control group by the concentration of apoprotein A1 and HDL cholesterol, but had lower content of HDL phospholipids and changed phospholipid composition: lower ratio of phosphatidylcholine and higher relative contents of lysophosphatidylcholine, sphingomyelin, and phosphatidylethanolamine. Parameters of HDL in patients with arterial hypertension associated with other components of metabolic syndrome did not differ from those in patients with isolated arterial hypertension. The observed changes in HDL in patients with arterial hypertension alone or in combination with other components of metabolic syndrome can impair functional capacity of HDL in reverse cholesterol transport, which increases the risk of atherosclerosis.
引用
收藏
页码:320 / 322
页数:2
相关论文
共 50 条
  • [1] Parameters of high-density lipoproteins in patients with arterial hypertension in combination with other components of metabolic syndrome
    Ozerova, I. N.
    Perova, N. V.
    Shchel'tsyna, N. V.
    Mamedov, M. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 143 (03) : 320 - 322
  • [2] Combination of the metabolic syndrome components in patients with arterial hypertension and their relationship with dyslipidemia
    Oganov, RG
    Perova, NV
    Mamedov, MN
    Metelskaya, VA
    TERAPEVTICHESKII ARKHIV, 1998, 70 (12) : 19 - 23
  • [3] Metabolic abnormalities: high-density lipoproteins
    Barter, P
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2004, 33 (02) : 393 - +
  • [4] Metabolic syndrome components in arterial hypertension
    Marchi-Alves, Leila Maria
    Rigotti, Ariane Ranzani
    Nogueira, Maria Suely
    Cesarino, Claudia Bernardi
    de Godoy, Simone
    REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2012, 46 (06) : 1349 - 1354
  • [5] HIGH-DENSITY LIPOPROTEINS - BIOCHEMICAL AND METABOLIC FACTORS
    GOTTO, AM
    AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (04): : B2 - B4
  • [6] Metabolism and function of high-density lipoproteins (HDL) in children with metabolic syndrome (MS)
    Garcia, L.
    Anaya, B.
    Juarez, M.
    Perez, O.
    HORMONE RESEARCH, 2008, 70 : 11 - 11
  • [7] Immunolocalization of high-density lipoproteins in arterial walls of rats
    Yang, VC
    Chou, WT
    Lee, TY
    Kao, CH
    ATHEROSCLEROSIS, 1998, 136 : S64 - S64
  • [8] Immunolocalization of high-density lipoproteins in arterial walls of rats
    Yang, VC
    Lee, TY
    Hwang, GY
    Kao, CH
    Chen, JK
    ATHEROSCLEROSIS, 1999, 142 (02) : 269 - 277
  • [9] EFFECT OF EXERCISE CONDITIONING ON PLASMA HIGH-DENSITY LIPOPROTEINS AND OTHER LIPOPROTEINS
    LIPSON, LC
    BONOW, RO
    SCHAEFER, EJ
    BREWER, HB
    LINDGREN, FT
    ATHEROSCLEROSIS, 1980, 37 (04) : 529 - 538
  • [10] HYPERTENSION, CHANGES IN HIGH-DENSITY LIPOPROTEINS AND ANTIHYPERTENSIVE THERAPY
    FLAMENBAUM, W
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (19): : I54 - I57